Kupecs, 2003 - Google Patents
Glycated hemoglobin test hits OTC marketKupecs, 2003
- Document ID
- 2123401499737908505
- Author
- Kupecs D
- Publication year
- Publication venue
- Nurse Practitioner
External Links
Snippet
The FDA has approved the first over-the-counter single-use glycated hemoglobin test for diabetics to monitor their glycemic control at home. With the Metrika AlcNow, diabetic patients can now avoid laboratory visits, venipunctures in the arm, and delays in receiving …
- 108091005979 glycated hemoglobin 0 title abstract description 6
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes electrical and mechanical details of in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N2035/00178—Special arrangements of analysers
- G01N2035/00326—Analysers with modular structure
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alto et al. | Assuring the accuracy of home glucose monitoring. | |
Tonyushkina et al. | Glucose meters: a review of technical challenges to obtaining accurate results | |
Clarke et al. | A history of blood glucose meters and their role in self-monitoring of diabetes mellitus | |
RU2411001C2 (en) | Measurement instrument with multi-level user interface | |
Goldstein et al. | Tests of glycemia in diabetes | |
CN102802508B (en) | Method, system, and computer program product for providing both an estimated true mean blood glucose value and estimated glycated hemoglobin (HbA1c) value from structured spot measurements of blood glucose | |
US20110196213A1 (en) | Display For Biological Values | |
Gerber et al. | ASVCP guidelines: quality assurance for portable blood glucose meter (glucometer) use in veterinary medicine | |
WO2006120656A1 (en) | A mobile chemistry and haematology analyser with an integrated diagnostic database | |
Fink et al. | Effect of high altitude on blood glucose meter performance | |
Kristensen et al. | Standardized evaluation of nine instruments for self-monitoring of blood glucose | |
Smaldone | Glycemic control and hemoglobinopathy: when A1C may not be reliable | |
Khadilkar et al. | Current concepts in blood glucose monitoring | |
Boren et al. | Analytical and clinical performance of blood glucose monitors | |
Little | Recent progress in glycohemoglobin ([HbA. sub. 1c]) testing | |
RU2686048C2 (en) | Method and device for determining glucose level in patient's physiological liquid and computer program product | |
Blake et al. | Point-of-care testing for diabetes | |
Kilic Baygutalp et al. | The comparison of two glucose measurement systems: POCT devices versus central laboratory | |
Nowatzke et al. | Whole blood international normalization ratio measurements in children using near-patient monitors | |
Solnica et al. | Quality control of self-monitoring of blood glucose: why and how? | |
Kupecs | Glycated hemoglobin test hits OTC market | |
Kristensen et al. | Self-monitoring of blood glucose with a focus on analytical quality: an overview | |
Hellman | Glycemic Variability in the Use of Point-of-Care Glucose Meters. | |
Kendall et al. | Accuracy and utility of a 10-test disk blood glucose meter | |
Voulgari et al. | Accuracy and precision of glucose monitoring are relevant to treatment decision-making and clinical outcome in hospitalized patients with diabetes |